• Nem Talált Eredményt

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen

N/A
N/A
Protected

Academic year: 2022

Ossza meg "Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen"

Copied!
13
0
0

Teljes szövegt

(1)

at the University of Pécs and at the University of Debrecen

Identification number: TÁMOP-4.1.2-08/1/A-2009-0011

(2)

ETHICAL ISSUES

Dr. Judit Pongrácz

Three dimensional tissue cultures and tissue engineering – Lecture 27

at the University of Pécs and at the University of Debrecen

Identification number: TÁMOP-4.1.2-08/1/A-2009-0011

(3)

No ethical issues raised

• Autologous cells

• No life threatening conditions

(4)

More ethical questions

• Advanced human tissue engineering therapies may also be used for life-threatening conditions

• Embryonic stem cells

• Xenogeneic cells

(5)

Regulation in Europe

• Best regulated at European level

• European framework laws

• Directives adopted by the European Commission and the European Parliament must be incorporated in national law

(6)

The most relevant documents

• Charter of Fundamental Rights of the EU

• Convention on Biomedicine

(7)

Ruling in 2011

A single cell from an embryo can be considered as a human being.

(8)

USA

• Embryonic stem cells cannot be used

• Only established cell lines can be used in research

• Adult stem cells can be applied in research

(9)

ECONOMIC

SIGNIFICANCE

Dr. Judit Pongrácz

Three dimensional tissue cultures and tissue engineering – Lecture 28

at the University of Pécs and at the University of Debrecen

Identification number: TÁMOP-4.1.2-08/1/A-2009-0011

(10)

Biotechnology

• Medical

• Pharmaceutical

• Agricultural, etc

(11)

Significance in the US

• In 2001, 3,300 scientists and support staff worked in tissue engineering alone

• Over 70 start-up companies

• Investment of 3.5 billion US dollars

(12)

Significance in the EU

• Fast growing

• STILL

• No venture capital in Europe

(13)

Big Pharma

• Refocusing to cell based therapies

• Novel therapeutic approaches just in treatment of diabetic patients alone

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

development; Drosophila segmentation Nuclear hormone receptors Glucocorticoid receptor, estrogen receptor,. testosterone receptor, retinoic acid receptors Secondary

• EBF: early B-cell factor, B-cell fate determinant, turns on B- cell specific genes. • Pax5: in its absence cells are blocked at pro-B stage, self renew, broad

ZAP-70 is normally expressed in T cells and natural killer cells and has a critical role in the initiation of T-cell signaling. • ZAP-70 in B cells is used as a prognostic marker

• Cytokines: TNF, IL-1, IL-4, IL-5, IL-6, IL-13, MIP-1a, IL-3,

• After ligand binding, the tyrosine (Y) residue of the ITAM is phosphorylated by tyrosine kinases, and a signaling cascade is generated within the cell.. • An ITAM is present in

Cytokine binding dimerizes the receptor, bringing together the cytoplasmic JAKs, which activate each. other and phosphorylate

Member of a family of proteins termed neutrophins that promote proliferation and survival of neurons; neutrophin receptors are a class of related proteins first identified

• Scavenger receptors bind to bacterial cell wall components such as LPS, peptidoglyan and teichoic acids and stressed, infected, or injured cells. Scavenger